BioRestorative Therapies Announces New Initiative to Target Polycystic Ovarian Syndrome

    NEXT STORY
    T2 Biosystems Receives Funding from BARDA to Advance Technology for Diagnosis and Treatment of Bloodstream Infections
    PREV STORY
    Athenex Announces Initiation of Phase I Clinical Study in China of KX2-361 Oral by Partner Guangzhou Xiangxue Pharmaceutical
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Celsion Corporation Announces Issuance of Two New Patents for ThermoDox®

    LAWRENCEVILLE, N.J., Jan. 18, 2017 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), a clinical stage ...

    author_avatar
    NASDAQ Market News

    Sandoz receives European Commission approval for biosimilar Hyrimoz® (adalimumab)

    Biosimilar Hyrimoz® (adalimumab) approved for use in all same indications as reference medicine*** including ...

    author_avatar
    NASDAQ Market News

    Inovio Pharmaceuticals and GeneOne Life Science Initiate Patient Recruitment for MERS Vaccine Trial

    PLYMOUTH MEETING, Pa., Jan. 28, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today ...

    author_avatar
    NASDAQ Market News